Linear organopolysiloxane having different functional groups at terminals, and a method for producing same
US-2018362716-A1 · Dec 20, 2018 · US
US12459963B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12459963-B2 |
| Application number | US-202418597102-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 6, 2024 |
| Priority date | Aug 22, 2019 |
| Publication date | Nov 4, 2025 |
| Grant date | Nov 4, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides siloxane derivatives of amino acids that have surface-active properties. The amino acid can be naturally-occurring or synthetic, or they may be obtained via a ring-opening reaction of a lactam, such as caprolactam. The amino acid may be functionalized with a siloxane group to form a compound that is surface-active and has surfactant characteristics. The compounds have low critical micelle concentrations (CMC) as well as the ability to lower the surface tension of a liquid.
Opening claim text (preview).
The invention claimed is: 1 . A liquid medium, comprising: water; and a compound of Formula I: wherein R 1 and R 2 may be the same or different, and comprise at least one group selected from the group consisting of C 1 -C 6 alkyl, optionally the C 1 -C 6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate; n is an integer from 3 to 12; the terminal nitrogen is optionally further substituted with R 3 , wherein R 3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C 1 -C 6 alkyl; and an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, and iodide. 2 . The liquid medium of claim 1 , wherein R 1 and R 2 are methyl. 3 . The liquid medium of claim 1 , wherein n is 5. 4 . The liquid medium of claim 3 , wherein R 3 is hydrogen. 5 . The liquid medium of claim 4 , wherein the counterion is selected from the group consisting of chloride, bromide, and iodide. 6 . The liquid medium of claim 5 , wherein the counterion is chloride. 7 . The liquid medium of claim 3 , wherein R 3 is methyl. 8 . The liquid medium of claim 7 , wherein the counterion is selected from the group consisting of chloride, bromide, and iodide. 9 . The liquid medium of claim 8 , wherein the counterion is iodide. 10 . The liquid medium of claim 3 , wherein R 3 is an oxygen atom. 11 . The liquid medium of claim 3 , wherein R 3 is C 1 -C 6 alkyl, substituted with sulfonate. 12 . The liquid medium of claim 3 , wherein the compound is 6-(dimethylamino)-N-(3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl) oxy) trisiloxan-3-yl) propyl) hexanamide, having the following formula: 13 . The liquid medium of claim 6 , wherein the compound is 6-(dimethylamino)-N-(3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl) oxy) trisiloxan-3-yl) propyl) hexaminium chloride, having the following formula: 14 . The liquid medium of claim 9 , wherein the compound is 3 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl) oxy) trisiloxan-3-yl) propyl) amino)-N,N,N-trimethyl-6-oxohexan-1-aminium iodide, having the following formula: 15 . The liquid medium of claim 10 , wherein the compound is 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl) oxy) trisiloxan-3-yl) propyl) amino)-N,N-dimethyl-6-oxohexan-1-amine oxide, having the following formula: 16 . The liquid medium of claim 11 , wherein the compound is 4-((6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl) oxy) trisiloxan-3-yl) propyl) amino)-6-oxohexyl) dimethylammonio) butane-1-sulfonate, having the following formula: 17 . The liquid medium of claim 11 , wherein the compound is 5-((6-((3-(1, 1,1,5,5,5-hexamethyl-3-((trimethylsilyl) oxy) trisiloxan-3-yl) propyl) amino)-6-oxohexyl) dimethylammonio) pentane-1-sulfonate, having the following formula:
Silicon compounds · CPC title
Treatments not covered by a preceding group · CPC title
Aminocarboxylic acids (proteins and protein hydrolysates C09K23/30) · CPC title
Compounds with one or more Si-O-Si sequences (compounds with a ring containing only alternating Si and O atoms, i.e. cyclosilanes C07F7/21) · CPC title
Compounds having one or more O-Si linkage (for compounds with C-O-Si linkages see C07F7/18) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.